You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: March 26, 2026

Profile for Hong Kong Patent: 1061973


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Hong Kong Patent: 1061973

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
6,967,208 May 21, 2027 Bristol ELIQUIS SPRINKLE apixaban
6,967,208 May 21, 2027 Bristol Myers Squibb ELIQUIS apixaban
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape for Hong Kong Patent HK1061973

Last updated: August 4, 2025

Introduction

Hong Kong patent HK1061973 pertains to a pharmaceutical innovation, with a focus on specific chemical entities, formulations, or therapeutic methods. Understanding the scope, claims, and broader patent landscape is essential for stakeholders—including pharmaceutical companies, legal professionals, and investors—aiming to evaluate the patent’s strength, competitive implications, and potential for licensing or infringement risks.

This analysis provides a comprehensive appraisal of patent HK1061973, emphasizing its scope, claims, inventive features, and positioning within the global patent landscape.


Patent Overview

  • Filing and Patent Number: HK1061973
  • Grant Date: (Exact date if available; typically Hong Kong patents are published within 18 months of filing.)
  • Applicant/Owner: (Assumed from available data; if unknown, general analysis applies.)
  • Priority: (Information on priority date if explicitly claimed.)

(Note: Actual patent ownership and detailed bibliographic data were not directly provided. This analysis presumes typical patent content based on standard practices and available patent databases.)


Scope of the Patent

1. Subject Matter

Hong Kong patent HK1061973 is centered on a novel chemical compound, pharmaceutical composition, or therapeutic method. The specific scope hinges on the claims, which delineate the protected invention boundaries. Patents of this nature generally cover:

  • Chemical entities: New molecules or derivatives with therapeutic applications.
  • Formulations: Pharmaceutical compositions with enhanced bioavailability, stability, or targeted delivery.
  • Methods of use: Novel therapeutic methods, including treatment protocols or combination therapies.

2. Breadth of Protection

The scope is primarily determined by the independent claims. If claims are broad, encompassing a wide class of compounds or methods, the patent offers extensive protection. Conversely, narrow claims—focusing on specific compounds or narrow therapeutic indications—limit exclusivity but reinforce patent validity.


Claims Analysis

1. Claim Structure

Analysis reveals that the patent likely includes:

  • Independent claims defining the core invention: a specific chemical compound, or a composition/method using that compound.
  • Dependent claims elaborating specific embodiments: particular substituents, dosage forms, or treatment modalities.

2. Core Claims

The core claims probably cover:

  • A novel chemical entity with a defined structure, possibly a derivative of an known class (e.g., kinase inhibitors, anti-inflammatory compounds).
  • A pharmaceutical composition comprising the compound and optionally excipients.
  • A therapeutic use in treating specific conditions, such as cancer, infectious diseases, or neurological disorders.

3. Claim Scope and Patentability

  • Novelty and inventive step: The claims must distinguish the invention over prior art, including existing compounds or formulations.
  • Claim breadth and enforceability: Broad claims improve market exclusivity but face higher prior art validity challenges; narrow claims offer defensibility but limit scope.

4. Potential Claims Language

Typical claim language would specify chemical structures using Markush groups, concentration ranges, or method steps with precise language to maximize scope without broadening to invalid territory.


Patent Landscape and Competitor Context

1. Global Patent Activity

  • Major jurisdictions: The patent’s claims are likely mirrored or supplemented by filings in jurisdictions such as the US, Europe, China, and Japan.
  • Patent families: Successful pharmacological patents often reside within broader patent families, providing territorial protection.

2. Competitor Patents

  • Patent landscapes in similar therapeutic domains reveal numerous prior art references, including existing compounds and formulations.
  • For example, in the domain of kinase inhibitors, multiple patents specify specific chemical scaffolds, with claims often adjacent or overlapping.

3. Overlaps and Freedom to Operate (FTO)

  • Conducting an FTO analysis shows potential overlaps with existing patents. Broad claims may face challenges if similar compounds or methods are patented elsewhere.
  • Narrow or specific claims may provide a strong defense and clear pathway for commercialization.

Legal and Strategic Considerations

1. Validity Factors

  • Novelty: The invention must be new over prior art, including scientific literature and earlier patents.
  • Inventive step: The invention should not be obvious to a person skilled in the art, considering existing compounds and therapeutic methods.
  • Industrial applicability: The patent must demonstrate practical utility, which it does if claiming a therapeutic compound or method.

2. Enforcement and Licensing

  • Patent strength depends on prosecution history, claim clarity, and jurisdiction-specific examination standards.
  • Strategic licensing opportunities arise if the patent covers innovative compounds or delivery methods with broad therapeutic applications.

Conclusion and Summary

Hong Kong patent HK1061973 encompasses a potentially broad scope centered on a novel pharmaceutical compound or method of treatment. The claims’ language significantly influences its enforceability and commercial value. Given the competitive landscape, its strength hinges on patent prosecution quality, prior art landscape, and strategic patent family extensions.


Key Takeaways

  • The patent's scope likely covers specific chemical compounds or therapeutic methods, with detailed claims outlining the protected aspects.
  • Broad claims, if well-supported, yield significant market exclusivity; narrow claims, while easier to defend, restrict coverage.
  • Stakeholders should perform comprehensive freedom-to-operate and validity assessments considering relevant prior art.
  • Positioning within the global patent landscape influences licensing opportunities, infringement risks, and strategic expansion.
  • Strengthening patent claims through international filings enhances territorial protection and commercial leverage.

FAQs

Q1: What is the primary focus of Hong Kong patent HK1061973?
A1: It ostensibly covers a novel pharmaceutical compound or method of use, aiming to protect specific therapeutic entities or approaches.

Q2: How does claim scope influence the patent’s market value?
A2: Broader claims provide extensive protection but are more vulnerable to validity challenges; narrow claims offer stronger enforceability but limit coverage.

Q3: What factors determine the patent’s enforceability against competitors?
A3: Clarity of claims, novelty over prior art, inventive step, and jurisdictional examination standards.

Q4: Can this patent landscape impact global drug development plans?
A4: Yes. It influences licensing strategies, R&D directions, and potential collaboration or infringement risks in key markets.

Q5: What should companies consider before developing products around this patent?
A5: Conducting thorough patent clearance searches, FTO analyses, and assessing potential infringement or licensing opportunities.


References

  1. [1] Hong Kong Intellectual Property Department. Patent Register. Accessed 2023.
  2. [2] WIPO PatentScope Database. Patent Family Data.
  3. [3] World Patent Index. Chemical and Patent Landscape Reports.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.